Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Medical-Surgical Nursing

13.4 Muscular Dystrophy

Medical-Surgical Nursing13.4 Muscular Dystrophy

Learning Objectives

By the end of this section, you will be able to:

  • Discuss the pathophysiology, risk factors, and clinical manifestations for muscular dystrophy
  • Describe the diagnostics and laboratory values of muscular dystrophy
  • Apply nursing concepts and plan associated nursing care for patients with muscular dystrophy
  • Evaluate the efficacy of nursing care for patients with muscular dystrophy
  • Describe the medical therapies that apply to the care of muscular dystrophy

A muscular dystrophy (MD) is a rare genetic disorder that causes progressive muscle weakness over time (Figure 13.15). With over 30 specific types, MD has a wide range of variability in terms of age of diagnosis, severity, and affected muscles. However, all types are progressive, meaning they get more severe over time. Some of the more common types are briefly described in Table 13.4. In most cases, individuals diagnosed with MD will eventually be unable to walk and perform their own ADLs such as toileting or bathing.

Diagram showing progression of muscular dystrophy over time, labeling Normal Muscle and Atrophied Muscle
Figure 13.15 Progressive muscle weakness and atrophy occur over time with muscular dystrophy. (credit: modification of work from Anatomy and Physiology, 2e. attribution: Copyright Rice University, OpenStax, under CC BY 4.0 license)
Type Description
Duchenne muscular dystrophy (DMD)
  • DMD is the most-common type, affects 14 in 100,000 male individuals between the ages of 5 and 24.
  • It accounts for approximately half of the cases of MD.
  • It is an X-linked recessive genetic disorder, meaning that it primarily affects the male population.
  • It results from a complete absence of dystrophin, a protein involved in maintaining muscle strength and function.
  • Symptoms often become apparent during toddler years, when the child is beginning to walk.
Becker muscular dystrophy (BMD)
  • BMD is less severe than DMD.
  • It results from insufficient function of dystrophin.
  • It usually appears around age 11, but it may occur as late as one’s mid-twenties.
Myotonic dystrophy
  • This is the most-common MD that is first diagnosed during adulthood (usually between 20 and 30 years of age).
  • It prevents muscles from relaxing following contraction.
Facioscapulohumeral muscular dystrophy (FSHD)
  • FSHD affects the face, shoulders, and upper arms.
  • It often causes symptoms that affect the eyes first (e.g., difficulty opening eyelids).
  • Its onset is typically during adolescence, but it can be later.
  • Most affected individuals live a normal lifespan.
Limb-girdle muscular dystrophy (LGMD)
  • LGMD results in progressive muscle loss and weakness, especially in the hips and shoulders.
  • Several different subtypes with varying levels of severity exist.
Table 13.4 Types of Muscular Dystrophies (Muntoni et al., 2023; National Institute of Neurological Disorders and Stroke, n.d.)

Life-Stage Context

Muscular Dystrophy Diagnosis During Childhood

Most MDs are diagnosed during childhood, which increases the complexity of the disorder. The parents or caregivers of the child will be tasked with providing most of the care to the child in the home setting, highlighting the need for adequate education and training. Additionally, caregivers will likely need emotional support, as receiving a devastating diagnosis for their child can be life-altering. Nurses must not only treat the patient but also consider the needs of the parents and other involved caregivers and family members, such as siblings or grandparents.

Pathophysiology

The underlying pathophysiology of MD is caused by genetic mutations, either inherited or spontaneous. In most cases, the mutation that causes MD is inherited, meaning that it came from one or both parents. Though the specific pathophysiologic mechanism is still somewhat unknown, the mutation negatively affects muscle function, resulting in the degeneration of muscle fibers, decreased muscle mass, and progressive muscle weakness over time.

Clinical Manifestations

Clinical manifestations of MD vary depending on the specific type, but some of the more common findings include

  • loss of reflexes,
  • abnormal gait,
  • frequent falls or clumsiness,
  • difficulty standing from a sitting position or climbing stairs,
  • posture changes,
  • muscle weakness and atrophy,
  • contractures,
  • an abnormally curved spine, known as scoliosis,
  • impaired breathing,
  • enlarged calves, and
  • inability to open or close the eyes.

Because most MDs are diagnosed in childhood, it is often the child’s parents who notice the first signs that may indicate a muscular problem. Parents often report that their child is unable to run or jump, is “toe walking,” falls frequently, or has trouble standing up from a sitting position on the floor.

Assessment and Diagnostics

The first step in diagnosing MD involves a thorough review of the patient’s medical history. It is especially important to assess the patient’s family history, as many MDs are known to be genetically inherited. Additionally, a comprehensive physical examination may reveal clinical manifestations associated with MD, including muscle weakness, abnormal gait, or posture changes.

Diagnostics and Laboratory Values

Because MD often occurs secondary to genetic mutations, genetic testing is one of the most definitive diagnostic tests for the condition. In some cases, muscle biopsies can be conducted to examine muscle tissue more closely for signs of the condition. Beyond genetic testing and muscle biopsies, there are no diagnostic tests specific to MD, but several other laboratory and diagnostic tests can be used to assist in making the diagnosis (Table 13.5).

Diagnostic Test Expected Finding with Muscular Dystrophy
Serum creatine kinase (CK) CK may be elevated due to muscle breakdown and damage.
Electrocardiogram (ECG) Heart function may be altered or arrythmias may be present, especially in myotonic dystrophy.
Electromyography (EMG) Changes in the pattern of muscular electrical activity may indicate a muscular disorder such as MD.
Pulmonary function tests (PFTs) In more severe cases, PFTs reveal a suboptimal functioning of the lungs due to diaphragmatic muscle weakness.
Table 13.5 Diagnostic Tests Used to Assist in the Diagnosis of Muscular Dystrophy

Nursing Care of the Patient with Muscular Dystrophy

Most of the nursing care for patients with MD centers around maintaining the highest quality of life possible and minimizing the negative effects associated with progressive muscle weakness. While there is no definitive cure for MD, many nursing interventions seek to address specific challenges associated with muscle weakness, mobility issues, and potential complications (LaPelusa et al., 2024).

Recognizing Cues and Analyzing Cues

Because most cases of MD are diagnosed in childhood, it is often the parents who notice muscle abnormalities and bring in their children for further assessment and diagnosis. It is important for the nurse to communicate effectively with the parents and allow them to fully express their feelings and concerns. In addition to the information provided by the parents, the nurse will conduct a full physical assessment to determine if the child is exhibiting symptoms consistent with MD or a similar disorder. Cues that would indicate the child may have MD include an abnormal gait, muscle weakness, contractures, and an inability to stand from a sitting position.

Prioritizing Hypotheses, Generating Solutions, and Taking Action

Most of the nursing interventions for patients with MD center around maintaining muscle function and slowing the progression of the disorder. These interventions include

  • assisting with ADLs as needed,
  • promoting as much independence as possible,
  • helping with range of motion (ROM) exercises,
  • alternating rest and activity periods to combat fatigue and muscle weakness,
  • teaching deep breathing and relaxation techniques,
  • implementing fall-risk precautions as needed,
  • providing emotional support and teaching patient positive coping skills, and
  • coordinating care with other members of the health-care team, including physical and occupational therapists.

Evaluation of Nursing Care for the Patient with Muscular Dystrophy

Though MD is progressive, medical and nursing interventions can help slow the trajectory of the disorder. The nurse will need to evaluate the interventions to determine if the plan of care should be revised to ensure optimal patient outcomes.

Evaluating Outcomes

When evaluating outcomes for the patient with MD, the nurse will look for specific findings indicating the interventions have been successful. These findings include

  • improved muscle strength,
  • normal cardiac rhythm,
  • adequate oxygenation status, and
  • positive coping skills.

Medical Therapies and Related Care

There is no cure for MD, but some treatments may help with symptom relief. In many cases, long-term corticosteroids are used to help maintain muscle strength for as long as possible. However, the side effects of steroids include weight gain, weakened bones, and a decrease in immune function, all of which can be detrimental to the health of the patient. In these cases, the benefits of using long-term steroids must be weighed against the risks.

In recent years, several new medications have been developed specifically for the treatment of MD. One of these medications, eteplirsen (Exondys 51), works by targeting the specific genetic mutations that cause MD. In addition to these medications, patients with MD who have experienced heart damage may also require treatment with cardiac medications such as angiotensin-converting enzyme inhibitors (ACEIs) or beta blockers. Beyond pharmacological interventions, patients with MD also require therapy to prolong muscle function for as long as possible. Therapy interventions to prolong muscle function include

  • physical and occupational therapy,
  • ROM exercises,
  • low-impact aerobic exercise (e.g., swimming, walking),
  • braces, and
  • mobility aids (e.g., canes, walkers, wheelchairs).

For patients with cardiac or respiratory issues secondary to MD, use of a ventilator or insertion of a pacemaker may eventually be required.

Interdisciplinary Plan of Care

Interdisciplinary Care for Patients with MD

Nurses work with an interdisciplinary team and coordinate care for patients with MD.

  • The provider orders the treatment plan, including medications and any specialty referrals needed to manage the patient’s care.
  • The nurse implements the provider’s orders and educates the patient about their condition.
  • The respiratory therapist provides set-up, maintenance, and instructions for any pulmonary machines, such as a sleep apnea or ventilator; they also educate the patient on pulmonary exercises, such as incentive spirometer, and breathing treatments.
  • The case manager coordinates ancillary departments needed for a comprehensive plan of care, such as wound care or nutrition; they also coordinate resources and follow-up for the family once the patient is discharged.
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/medical-surgical-nursing/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/medical-surgical-nursing/pages/1-introduction
Citation information

© Sep 20, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.